Bristol-Myers Squibb | BMY - Operating Profit

Stock Price
57.62
Daily Change
1.63 2.91%
Monthly
8.59%
Yearly
-3.50%
Q1 Forecast
53.35

Bristol-Myers Squibb reported $3.64B in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 4.58B 1.13B Sep/2025
Abbott USD 2.25B 73M Dec/2025
ALKERMES USD 89.08M 3.9M Sep/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Drreddys Laboratories INR 14.33B 2.51B Dec/2025
Eli Lilly USD 8.39B 1.37B Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 764M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Merck USD 6.24B 318M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Prestige Brands USD 79.67M 7.91M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sanofi EUR 1.5B 2.29B Dec/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Zoetis USD 936M 63M Sep/2025